Tevogen Inc. Warrant
TVGNW
50 hedge funds and large institutions have $1.08M invested in Tevogen Inc. Warrant in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 0 closing their positions.
20% more capital invested
Capital invested by funds: $899K → $1.08M (+$183K)
2% more funds holding
Funds holding: 49 → 50 (+1)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$15.1K |
| 2 |
Parallax Volatility Advisers
San Francisco,
California
|
+$2.28K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$177 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
-$16.9K |
| 2 |
CS
Clear Street
New York
|
-$310 |
| 3 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
-$166 |
| 4 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
-$78 |
TVGNW Hedge Fund Activity: Q3 2023 in Review
50 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc. Warrant (TVGNW) for Q3 2023, worth a combined $1.08M — up 20% from $899K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new TVGNW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 4 trimmed.
The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $15.1K. The largest seller was Spartan Fund Management, cutting an estimated $16.9K.
- 50 institutional investors held Tevogen Inc. Warrant (TVGNW) as of Q3 2023, up from 49 in Q2 2023.
- Funds reported $1.08M of Tevogen Inc. Warrant stock for Q3 2023, up 20% quarter-over-quarter.
- 1 fund opened new Tevogen Inc. Warrant positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest Tevogen Inc. Warrant buyer in Q3 2023 was Shaolin Capital Management, an estimated $15.1K added.
- The largest Tevogen Inc. Warrant seller in Q3 2023 was Spartan Fund Management, an estimated $16.9K sold.
Based on aggregated 13F filings for Q3 2023.